These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome. Kurosaki T; Ueda S; Ishida T; Abe K; Ohno K; Matsuura T PLoS One; 2012; 7(6):e38379. PubMed ID: 22723857 [TBL] [Abstract][Full Text] [Related]
6. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Ranum LP; Day JW Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228 [TBL] [Abstract][Full Text] [Related]
7. Improvement of the diagnostic procedure in proximal myotonic myopathy/myotonic dystrophy type 2. Jakubiczka S; Vielhaber S; Kress W; Küpferling P; Reuner U; Kunath B; Wieacker P Neurogenetics; 2004 Feb; 5(1):55-9. PubMed ID: 14666402 [TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families. Saito T; Amakusa Y; Kimura T; Yahara O; Aizawa H; Ikeda Y; Day JW; Ranum LP; Ohno K; Matsuura T Neurogenetics; 2008 Feb; 9(1):61-3. PubMed ID: 18057971 [TBL] [Abstract][Full Text] [Related]
9. An expansion in the ZNF9 gene causes PROMM in a previously described family with an incidental CLCN1 mutation. Lamont PJ; Jacob RL; Mastaglia FL; Laing NG J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):343. PubMed ID: 14742629 [No Abstract] [Full Text] [Related]
10. Clinical and genetic analysis of a family with PROMM. Grewal RP; Zhang S; Ma W; Rosenberg M; Krahe R J Clin Neurosci; 2004 Aug; 11(6):603-5. PubMed ID: 15261229 [TBL] [Abstract][Full Text] [Related]
11. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Udd B; Krahe R Lancet Neurol; 2012 Oct; 11(10):891-905. PubMed ID: 22995693 [TBL] [Abstract][Full Text] [Related]
12. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181 [TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy type 2 and related myotonic disorders. Meola G; Moxley RT J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094 [TBL] [Abstract][Full Text] [Related]
14. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2. Raheem O; Olufemi SE; Bachinski LL; Vihola A; Sirito M; Holmlund-Hampf J; Haapasalo H; Li YP; Udd B; Krahe R Am J Pathol; 2010 Dec; 177(6):3025-36. PubMed ID: 20971734 [TBL] [Abstract][Full Text] [Related]
15. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene. Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798 [TBL] [Abstract][Full Text] [Related]
16. [Molecular and genetic aspects of the myotonic conditions]. Morales Montero F; Cuenca Berger P Rev Neurol; 2004 Apr 1-15; 38(7):668-74. PubMed ID: 15098190 [TBL] [Abstract][Full Text] [Related]
17. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2. Young NP; Daube JR; Sorenson EJ; Milone M Muscle Nerve; 2010 Jun; 41(6):758-62. PubMed ID: 20513102 [TBL] [Abstract][Full Text] [Related]
18. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2. Cardani R; Giagnacovo M; Botta A; Rinaldi F; Morgante A; Udd B; Raheem O; Penttilä S; Suominen T; Renna LV; Sansone V; Bugiardini E; Novelli G; Meola G J Neurol; 2012 Oct; 259(10):2090-9. PubMed ID: 22407275 [TBL] [Abstract][Full Text] [Related]